In summary, our findings demonstrate that lung adenocarcinomas harboring the EGFR-L858R mutation exhibit increased cancer cell invasive ability and enhanced MPE formation, effects mediated through ERK-dependent activation of CXCL12-CXCR4 signaling pathways. This evidence concerns the gene EGFR and cancer.